October 27, 2026 · Sports, Health & Nutrition Daily Digest
A digest of sports, fitness, health, and nutrition developments compiled for October 27, 2026, with summaries, links, and commentary.
I. Nutrition and Diet
1. JAMA Network Open: In 46 children of healthy weight, higher ultraprocessed-food intake tracked stronger dorsal striatal food-cue responses and later adiposity gain (Nutrition)
Summary:
A prospective cohort from the University of Southern California and Kaiser Permanente within the longitudinal BrainChild study appeared in JAMA Network Open and was reported on October 27 by India Today and others. Forty-six children of healthy weight (mean age 8.7 ± 1.1 years; 26 girls) had habitual ultraprocessed-food (UPF) energy share from multiple 24-hour recalls using NOVA, fMRI striatal responses to food cues at baseline, and BMI, body-fat percentage, and waist circumference one year later. Higher UPF intake was associated with greater dorsal striatal food-cue responses (β = 0.34, 95% CI 0.07–0.61) but not ventral striatum (β = 0.16, −0.14 to 0.46). Greater dorsal striatal responsivity was associated with one-year increases in BMI (β = 0.32, 0.02–0.62) and body-fat percentage (β = 0.44, 0.15–0.72); baseline UPF tracked a one-year increase in waist circumference (β = 0.38, 0.11–0.66). Including dorsal striatal responsivity attenuated the UPF associations with BMI and body-fat percentage by about 31% and 44%. The authors describe associative evidence that reward-related brain responses may sit on the path from childhood UPF intake to adiposity gain.
Links:
- JAMA Network Open — Ultraprocessed food, striatal response, and adiposity gain in children
- India Today — October 27 report on the JAMA childhood UPF study
Commentary:
In children of healthy weight, cutting household UPF snacks that pair fat with carbohydrate is the habit closest to this pathway hint; with only 46 participants, the result is not a settled verdict.
2. eBioMedicine: A secondary CARBFUNC analysis found a very low-carbohydrate, high–saturated-fat diet lowered triglycerides and remnant cholesterol without a significant apoB rise (Nutrition)
Summary:
Cathrine Loddervik and corresponding author Simon Dankel of the University of Bergen published a secondary analysis of the two-year CARBFUNC randomized trial on October 24 in eBioMedicine (Lancet family), summarized by News-Medical on October 27. One hundred ninety-three adults with obesity were assigned to an acellular carbohydrate-based diet, a cellular carbohydrate-based diet, or a low-carbohydrate high-fat diet (about 75% of energy from fat, including about 30% saturated fat); lipids and lipoprotein subclasses were measured by NMR. Attrition reached 162 participants (84%) by 24 months, and self-reported adherence was about 40–60% in the final year. Over the first 9–12 months, the low-carbohydrate high-fat arm showed larger reductions than comparators in VLDL particles, triacylglycerols, remnant cholesterol, and the TAG/HDL-C ratio, with larger increases in HDL-C, apoA1, and large-LDL–related markers; LDL-C rose mainly via large LDL particles, without significant increases in apoB or small LDLs. Some of the triglyceride, VLDL, remnant, and TAG/HDL-C advantages remained at 24 months. The authors interpret a pattern that may indicate greater lipid turnover, not a population prescription for doubling saturated fat.
Links:
- eBioMedicine — Lipid dynamics on carbohydrate- or saturated fat–based diets in CARBFUNC
- News-Medical — October 27 report on saturated fat and cardiovascular markers
Commentary:
In supervised adults with obesity, the measured pattern was lower triglycerides and remnants without a clear apoB rise; with more than four-fifths lost by year two, that is not a license to double saturated fat on your own, and follow-up still needs apoB and overall risk, not LDL-C alone.
3. JAMA Psychiatry: In a 20-person major-depression pilot crossover, depression and anxiety scores were lower on a low-ultraprocessed diet than on usual diet (Nutrition)
Summary:
An open-label randomized crossover pilot led by D. N. Chagwedera and colleagues at UCSF appeared online in JAMA Psychiatry on September 23 and was covered on October 27 by Medical Dialogues and others. Twenty adults with major depressive disorder (mean age about 43.7 years; 70% women), high baseline UPF intake, and at least one metabolic abnormality completed about four weeks of a low-UPF diet and four weeks of usual diet in random order, buying and preparing their own food; primary outcomes were feasibility and acceptability. Nineteen completed; mean adapted UPF screening scores fell from 10.10 at baseline to 1.42 after the low-UPF phase. Exploratory symptom contrasts versus usual diet favored the low-UPF period: PHQ-9 treatment difference −3.12 (95% CI −4.53 to −1.71), MADRS −10.78 (−13.9 to −7.66), GAD-7 −2.74 (−4.51 to −0.98), and QIDS −3.67 (−5.17 to −2.17). The authors state that symptom changes were exploratory and that caloric or macronutrient shifts cannot be separated from UPF reduction itself.
Links:
- JAMA Psychiatry — Pilot crossover of reducing ultraprocessed foods in depression
- Medical Dialogues — October 27 report on the JAMA Psychiatry pilot
Commentary:
For depression with a high-UPF diet, cutting ultraprocessed snacks is a trial-worthy adjunct habit; with 20 people, no blinding, and symptoms not primary, it does not replace standard care.
II. Exercise and Training Science
4. ASBMR 2026: Preliminary FORTIFY Bones results—only high-intensity resistance training raised lumbar BMD by about 1% in older adults with low bone mass (Training)
Summary:
Lora Giangregorio of the University of Waterloo and colleagues presented preliminary findings from the FORTIFY Bones randomized trial at the American Society for Bone and Mineral Research 2026 meeting, reported by Medscape on October 27. Three hundred twenty-four adults (mean age about 67 years, mostly women) with low bone mass were assigned to home posture-and-balance control, moderate-intensity resistance training (about 12 repetitions short of failure), or high-intensity resistance training (about six repetitions to near failure), twice weekly for 12 months, including squats, deadlifts, step-ups, hip thrusts, bench press, and rows. Median adherence was about 92% and 86% in the moderate and high groups; assessment retention was about 91%. In intention-to-treat analyses, combined resistance training did not differ from control for lumbar spine, total hip, or femoral neck BMD; high intensity showed a modest, statistically significant lumbar-spine BMD advantage of about 1% versus control and versus moderate intensity (P < 0.04), without matching effects at the hip or femoral neck. The authors stress that the change is small and that precise effect sizes await full analysis; registration NCT05541432.
Links:
- Medscape — October 27 FORTIFY Bones report on high-intensity training and lumbar BMD
- ClinicalTrials.gov — FORTIFY Bones (NCT05541432)
Commentary:
For screened older adults with low bone mass who can lift safely, a high-intensity target near six repetitions is the load that sat next to the lumbar BMD signal; moderate intensity did not separate BMD here, and about 1% should not be treated as a finalized prescription before the full paper.
5. Antioxidants: In 45 inactive middle-aged and older women, 14 weeks of combined aerobic and resistance training improved function before redox-related DNA methylation shifted (Training)
Summary:
Guilherme da Silva Rodrigues, Ivo Vieira de Sousa Neto, and Carlos Roberto Bueno Júnior of the University of São Paulo published a single-arm longitudinal study on October 27 in Antioxidants. Forty-five physically inactive women completed supervised aerobic and resistance exercise three times weekly for 14 weeks; blood pressure, strength, agility, six-minute walk distance, and whole-blood DNA methylation (Illumina EPIC) were assessed at baseline and weeks 7 and 14. Blood pressure, strength, agility, and walk distance improved over time. Hypomethylated CpGs were detected in CAT, SOD1, TXNRD1, TGFB1, and NFE2L2 across contrasts; several CpGs remained significant after false-discovery-rate control in the week-14-versus-baseline contrast. SOCS1 cg06295404 appeared in two sequential contrasts; NFE2L2 cg07613405 methylation was associated with six-minute walk distance. The authors note the absence of a control group and call for independent replication before causal claims.
Links:
Commentary:
Middle-aged and older women can trade three weekly aerobic-plus-resistance sessions for blood pressure, strength, and walking gains first; methylation shifts are accompanying observations, not a lab test to order this week.
6. American Journal of Physiology–Renal Physiology: After 12 weeks of home exercise in 25 people with stage 3–5 CKD, muscle capillarization and oxidative capacity rose without significant fiber-size change (Training)
Summary:
Sarah E. Brashear, Lucas R. Smith, and colleagues at the University of California, Davis reported a randomized controlled pilot analysis online on October 7, covered on October 27 by AgingResearch.News and others. Twenty-five adults with nondialysis stage 3–5 chronic kidney disease (19 exercise, 6 usual care) completed a 12-week personalized home program of high-intensity interval training, power walking, and strength work, with vastus lateralis biopsies before and after. The exercise group showed no significant changes in fiber size, fiber type, or satellite-cell number, and collagen and extracellular-matrix fibrosis measures did not change significantly, while fibro-adipogenic progenitors decreased; muscle capillarization and in vivo oxidative capacity increased, with a trend toward longer walking distance. The authors conclude that an endurance-focused home program can elicit vascular and oxidative adaptations in CKD even without short-term fiber hypertrophy. Related feasibility work had reported about 90% adherence and no protocol-related adverse events.
Links:
- American Journal of Physiology–Renal Physiology — Skeletal muscle adaptation to home exercise in CKD
- AgingResearch.News — October 27 report on CKD home-exercise muscle biopsies
Commentary:
For medically cleared nondialysis CKD, a home mix of intervals and strength is more likely to buy muscle oxygen use and capillaries in the short term than thicker fibers; with only six usual-care participants, do not over-generalize.
III. Evidence and Clarification
7. Journal of Experimental Medicine: Pantethine eased psoriasis in mice, and a 24-person adjunctive trial suggested symptom improvement with topical therapy (Evidence)
Summary:
Wei-Na Zhang, Qing Xia, Ai-Ling Li, and Tao Zhou of the State Key Laboratory of Biomedical Analysis in Beijing, with Cheng-Xin Li of the First Medical Center of Chinese PLA General Hospital, published on October 27 in the Journal of Experimental Medicine. Vanin enzymes were elevated in dendritic cells from psoriasis and other autoimmune diseases, accelerating conversion of pantethine to vitamin B5 alongside higher cholesterol synthesis and dendritic-cell hyperactivation; pantethine replenishment or Vanin inhibition reduced cholesterol load and dendritic-cell activation and eased psoriasis in mice. In a 24-patient investigator-initiated trial, all participants used topical calcipotriene/betamethasone, and half also received pantethine tablets for 12 weeks; the pantethine arm improved more, especially with elevated baseline cholesterol. The authors frame the human results as proof of concept for feasibility, not direct mechanistic validation in people, and not a replacement for standard care.
Links:
- Journal of Experimental Medicine — Vanin–pantethine axis and inflammatory disease (DOI)
- News-Medical — October 27 report on pantethine and psoriasis
Commentary:
Psoriasis care still starts with topical therapy and dermatology; pantethine is at most a specialist question when cholesterol is high, and a 24-person trial does not justify self-dosing.
8. FDA: Arthritis and osteoporosis product Ultra Bon contains undeclared diclofenac (Evidence)
Summary:
On October 23 the U.S. Food and Drug Administration advised consumers not to buy or use Ultra Bon, a product promoted for arthritis, pain, and osteoporosis on various websites, including eBay, and possibly in some retail stores. Laboratory analysis confirmed undeclared diclofenac, an NSAID. The FDA notes that NSAIDs can raise risks of serious heart events and gastrointestinal bleeding, ulcers, or perforation, and can interact with other NSAID-containing products. The notice is part of ongoing alerts on products marketed as supplements or foods with hidden drug ingredients, and states that the agency cannot test every such product on the market.
Links:
Commentary:
Treat aggressively marketed “natural” joint or bone powders as prescription-drug risk until proven otherwise; joint pain and bone loss belong in diagnosed care with approved drugs and exercise, not unlabeled bottles.
IV. Sleep and Mental Health
9. British Journal of Psychiatry: About 23% of an Australian depression genetics cohort met a “circadian” subtype and reported poorer SSRI/SNRI response (Sleep)
Summary:
Emiliana Tonini, Jacob J. Crouse, and colleagues used cross-sectional data from the Australian Genetics of Depression Study, published online October 20 in the British Journal of Psychiatry and interpreted by Scientific American on October 27. Among 11,380 participants with depression, those meeting at least three of six binary circadian-associated features (social jetlag, seasonality, delayed sleep midpoint, evening chronotype, morning tiredness, hypersomnia) were labeled circadian subtype: 2,604 people (23%; about 80% women; mean age 37.87 ± 13.62 years). That group reported earlier onset, more (hypo)manic-like and psychotic-like experiences, suicidality, distress, and somatic complaints, plus weight gain in depressive episodes (all P < 0.001); poorer self-reported response to SSRIs (OR 0.88, 95% CI 0.82–0.94) and SNRIs (OR 0.89, 0.83–0.97); and more side effects. Polygenic scores linked the subtype to higher risk for ADHD, depression, anxiety, bipolar disorder, BMI, triglycerides, IL-6, insulin resistance, later sleep midpoint, and insomnia. The authors say independent replication is required before clinical reclassification.
Links:
- British Journal of Psychiatry — Clinical and genetic correlates of a circadian depression subtype
- Scientific American — October 27 report on circadian depression
Commentary:
If depression comes with long-standing circadian disruption and weak antidepressant response, tell the clinician the sleep timing and morning fatigue plainly; do not self-label a new subtype, and discuss light or melatonin only under specialist guidance.
10. BMC Public Health: Among 9,736 workers in Gansu, about 27.8% of the work-stress–depression link ran through sleep, with sleep quality contributing most (Sleep)
Summary:
Binbin Lin, Yanan Wu, and colleagues analyzed cross-sectional 2025 Worker Health Survey data from Gansu Province, published October 27 in BMC Public Health. In 9,736 workers, Bayesian mediation estimated that the statistical indirect association of work stress with depressive symptoms through overall sleep problems accounted for about 27.8% of the total association. Parallel multiple mediation compared sleep quality, sleep disturbance, sleep duration, and sleep latency; a nonlinear model better captured a U-shaped duration–depression link. Under that nonlinear parallel model, sleep quality accounted for about 50.7% of the estimated total indirect association, sleep disturbance 37.2%, duration 9.2%, and latency 2.9%. The authors argue that sleep dimensions reflect distinct recovery facets rather than interchangeable proxies, and that the cross-sectional design cannot establish causal order.
Links:
Commentary:
Under high work stress, prioritize how restorative and unbroken sleep feels over total hours alone; duration still shows a U-shape, so longer sleep is not an antidepressant prescription.
V. Public Health and Disease Prevention
11. Annals of Internal Medicine: Modeling projects about 83% more chronic hepatitis B infections in the 2026 birth cohort under shared decision-making versus universal birth dose (Public health)
Summary:
Amir M. Mohareb, Emily P. Hyle, and colleagues at Massachusetts General Hospital used a Markov cohort model published October 20 in Annals of Internal Medicine and reported by Live Science on October 27. The target was one U.S. birth cohort of about 3.6 million infants over 20 years, comparing universal birth-dose vaccination, deferred vaccination at two months, and shared decision-making. Base case: universal birth dose projected 255 childhood chronic infections (95% uncertainty interval 130–530); deferred rose to 303 (about 19% higher); shared decision-making to 467 (about 83% higher). HBV-susceptible people at year 20 rose from about 232,000 under universal birth dose to about 474,000 deferred and about 1,806,000 under shared decision-making. The authors conclude that universal birth-dose recommendations should be restored; limitations include uncertainty in horizontal infection risk. Funding came from the National Institute of Allergy and Infectious Diseases.
Links:
- Annals of Internal Medicine — Projected effect of childhood schedule changes on chronic HBV
- Live Science — October 27 report on the hepatitis B birth-dose model
Commentary:
The default for newborns remains an early hepatitis B birth dose; “decide later with the doctor” maps in this model to many more chronic infections and a larger susceptible adult pool, not a free flexibility option.
12. CNBC: U.S. measles cases exceed 4,400 with at least three deaths as kindergarten MMR coverage falls to 92.4% (Public health)
Summary:
CNBC reported on October 27 that the United States has logged more than 4,400 measles cases and at least three deaths this year, the worst outbreak in more than three decades. CDC-aggregated data show kindergarten MMR series completion at 92.4% for the 2025–2026 school year, below the roughly 95% threshold often cited to prevent sustained transmission, leaving about 280,000 kindergarteners without a completed series; exemptions rose to 4.2%. Two MMR doses are about 97% effective against measles and one dose about 93%. Public-health experts tie the resurgence to pockets of low coverage and declining trust, with implications for responses to other vaccine-preventable and emerging threats. The piece is a coverage and outbreak synthesis, not a new vaccine-efficacy trial.
Links:
Commentary:
For school-age children, check unfinished MMR doses first; when community coverage sits near 92%, individual missed shots scale through classrooms and childcare.
Today's Summary
- Diet: Childhood UPF tracked dorsal striatal responsivity and one-year adiposity gain; a depression pilot saw lower symptom scores on a low-UPF diet; CARBFUNC lipid shifts under very high saturated fat are not a DIY license to double SFA.
- Training: Preliminary lumbar BMD gains of about 1% appeared only with high-intensity resistance in low bone mass; combined training improved function before methylation changes in older women; CKD home exercise bought capillaries and oxidative capacity before fiber size.
- Sleep and evidence: About one in four people with depression met a circadian subtype with poorer self-reported drug response; sleep quality and disturbance outweighed duration in a work-stress pathway; pantethine remains a small adjunctive clue, while Ultra Bon is an undeclared-diclofenac warning.
- Public health: Shared decision-making on hepatitis B birth dose projected about 83% more chronic infections; measles and 92.4% kindergarten MMR coverage underline vaccination gaps the same day.
Daily Framing:
Today in the sport/health/nutrition cycle was a “defaults of processing, intensity, and shots” day—UPF and reward circuits, the resistance-intensity threshold for bone, hepatitis B at birth, and MMR coverage all favor established defaults over middling loads or deferred decisions.
This digest is compiled from real-time search results and is for reference only.